Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Tamura

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Oncology|October 8, 2005
Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancerMiho Hara, Satoko Matsueda, Mayumi Tamura, et al.
International Journal of Molecular Sciences|August 29, 2024
Galectin-2 Agglutinates <i>Helicobacter pylori</i> via Lipopolysaccharide Containing H Type I Under Weakly Acidic ConditionsTakaharu Sasaki, Midori Oyama, Mao Kubota, et al.
Vaccine|September 12, 2007
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapyShigeru Yutani, Akira Yamada, Kazumi Yoshida, et al.
Biological & Pharmaceutical Bulletin|December 3, 2023
Method for Preparing Recombinant Galectin-2 Protein without Escherichia coli-Specific Post-translational ModificationsMayumi Tamura, Norihiko Fujii, Tomoharu Takeuchi, et al.
Journal of Biochemistry|April 29, 2016
Identification of the cysteine residue responsible for oxidative inactivation of mouse galectin-2Mayumi Tamura, Akari Sasai, Rika Ozawa, et al.
Carbohydrate Research|May 31, 2015
Preparation of a polyclonal antibody that recognizes a unique galactoseβ1-4fucose disaccharide epitopeTomoharu Takeuchi, Kazusa Nishiyama, Saori Saito, et al.
Glycobiology|March 14, 2013
Structural basis of preferential binding of fucose-containing saccharide by the Caenorhabditis elegans galectin LEC-6Hisayoshi Makyio, Tomoharu Takeuchi, Mayumi Tamura, et al.
Carbohydrate Research|July 30, 2011
Caenorhabditis elegans proteins captured by immobilized Galβ1-4Fuc disaccharide units: assignment of 3 annexinsTomoharu Takeuchi, Kazusa Nishiyama, Atsushi Yamada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the peripheryShoko Tanaka, Mamoru Harada, Takashi Mine, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancerRumi Gohara, Nobue Imai, Toru Rikimaru, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Oncology|October 8, 2005
Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancerMiho Hara, Satoko Matsueda, Mayumi Tamura, et al.
International Journal of Molecular Sciences|August 29, 2024
Galectin-2 Agglutinates <i>Helicobacter pylori</i> via Lipopolysaccharide Containing H Type I Under Weakly Acidic ConditionsTakaharu Sasaki, Midori Oyama, Mao Kubota, et al.
Vaccine|September 12, 2007
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapyShigeru Yutani, Akira Yamada, Kazumi Yoshida, et al.
Biological & Pharmaceutical Bulletin|December 3, 2023
Method for Preparing Recombinant Galectin-2 Protein without Escherichia coli-Specific Post-translational ModificationsMayumi Tamura, Norihiko Fujii, Tomoharu Takeuchi, et al.
Journal of Biochemistry|April 29, 2016
Identification of the cysteine residue responsible for oxidative inactivation of mouse galectin-2Mayumi Tamura, Akari Sasai, Rika Ozawa, et al.
Carbohydrate Research|May 31, 2015
Preparation of a polyclonal antibody that recognizes a unique galactoseβ1-4fucose disaccharide epitopeTomoharu Takeuchi, Kazusa Nishiyama, Saori Saito, et al.
Glycobiology|March 14, 2013
Structural basis of preferential binding of fucose-containing saccharide by the Caenorhabditis elegans galectin LEC-6Hisayoshi Makyio, Tomoharu Takeuchi, Mayumi Tamura, et al.
Carbohydrate Research|July 30, 2011
Caenorhabditis elegans proteins captured by immobilized Galβ1-4Fuc disaccharide units: assignment of 3 annexinsTomoharu Takeuchi, Kazusa Nishiyama, Atsushi Yamada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the peripheryShoko Tanaka, Mamoru Harada, Takashi Mine, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancerRumi Gohara, Nobue Imai, Toru Rikimaru, et al.
Pageof 4